NITRILE-CONTAINING ANTIVIRAL COMPOUNDS
The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SAMMONS, Matthew Forrest REESE, Matthew Richard WEI, Liuqing TUTTLE, Jamison Bryce YANG, Qingyi VERHOEST, Patrick Robert PETTERSSON, Martin Youngjin OWEN, Dafydd Rhys YANG, Xiaojing |
description | The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA202108834B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA202108834B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA202108834B3</originalsourceid><addsrcrecordid>eNrjZFDz8wwJ8vRx1XX29wtx9PTz9HNXcPQL8QzzDHL0UXD29w3wD_VzCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGRoYGFhbGJk7GxKgBAOahI-s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><source>esp@cenet</source><creator>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</creator><creatorcontrib>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</creatorcontrib><description>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</description><language>eng</language><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230426&DB=EPODOC&CC=ZA&NR=202108834B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230426&DB=EPODOC&CC=ZA&NR=202108834B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAMMONS, Matthew Forrest</creatorcontrib><creatorcontrib>REESE, Matthew Richard</creatorcontrib><creatorcontrib>WEI, Liuqing</creatorcontrib><creatorcontrib>TUTTLE, Jamison Bryce</creatorcontrib><creatorcontrib>YANG, Qingyi</creatorcontrib><creatorcontrib>VERHOEST, Patrick Robert</creatorcontrib><creatorcontrib>PETTERSSON, Martin Youngjin</creatorcontrib><creatorcontrib>OWEN, Dafydd Rhys</creatorcontrib><creatorcontrib>YANG, Xiaojing</creatorcontrib><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><description>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDz8wwJ8vRx1XX29wtx9PTz9HNXcPQL8QzzDHL0UXD29w3wD_VzCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGRoYGFhbGJk7GxKgBAOahI-s</recordid><startdate>20230426</startdate><enddate>20230426</enddate><creator>SAMMONS, Matthew Forrest</creator><creator>REESE, Matthew Richard</creator><creator>WEI, Liuqing</creator><creator>TUTTLE, Jamison Bryce</creator><creator>YANG, Qingyi</creator><creator>VERHOEST, Patrick Robert</creator><creator>PETTERSSON, Martin Youngjin</creator><creator>OWEN, Dafydd Rhys</creator><creator>YANG, Xiaojing</creator><scope>EVB</scope></search><sort><creationdate>20230426</creationdate><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><author>SAMMONS, Matthew Forrest ; REESE, Matthew Richard ; WEI, Liuqing ; TUTTLE, Jamison Bryce ; YANG, Qingyi ; VERHOEST, Patrick Robert ; PETTERSSON, Martin Youngjin ; OWEN, Dafydd Rhys ; YANG, Xiaojing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA202108834B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>SAMMONS, Matthew Forrest</creatorcontrib><creatorcontrib>REESE, Matthew Richard</creatorcontrib><creatorcontrib>WEI, Liuqing</creatorcontrib><creatorcontrib>TUTTLE, Jamison Bryce</creatorcontrib><creatorcontrib>YANG, Qingyi</creatorcontrib><creatorcontrib>VERHOEST, Patrick Robert</creatorcontrib><creatorcontrib>PETTERSSON, Martin Youngjin</creatorcontrib><creatorcontrib>OWEN, Dafydd Rhys</creatorcontrib><creatorcontrib>YANG, Xiaojing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAMMONS, Matthew Forrest</au><au>REESE, Matthew Richard</au><au>WEI, Liuqing</au><au>TUTTLE, Jamison Bryce</au><au>YANG, Qingyi</au><au>VERHOEST, Patrick Robert</au><au>PETTERSSON, Martin Youngjin</au><au>OWEN, Dafydd Rhys</au><au>YANG, Xiaojing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NITRILE-CONTAINING ANTIVIRAL COMPOUNDS</title><date>2023-04-26</date><risdate>2023</risdate><abstract>The invention relates to the use as a medicament of a compound of formula Ih-1a, Ih-1b, Ih-1c, Ii-1a, Ii-1b, Ii-1c, Ij-1a, Ij-1b, Ij-1c, Ik-a, Ik-b or Ik-c:wherein R4 is defined herein; or a solvate or hydrate thereof, or a pharmaceutically acceptable salt of said compound, solvate or hydrate. These compounds are useful in treating coronavirus infections such as COVID-19.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_ZA202108834B |
source | esp@cenet |
title | NITRILE-CONTAINING ANTIVIRAL COMPOUNDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAMMONS,%20Matthew%20Forrest&rft.date=2023-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA202108834B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |